Investor Tips New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt. Articles You May Like Revisiting 5 Small Cap AI Stocks: Still Buys? Is Adobe (ADBE) A ‘Buy’ Ahead of Its Upcoming Earnings Announcement?